Skip to main content

Advertisement

Log in

Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids

  • SHORT COMMUNICATION
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract 

· Background: The purpose of the study is to demonstrate the development of subretinal fibrotic scar formation in central serous chorioretinopathy (CSCR) that developed during systemic corticosteroid treatment. · Methods: The clinical and photographic records of a patient in whom an unusual manifestation of severe central serous chorioretinopathy developed during systemic corticosteroid treatment were reviewed. Results: A 34-year-old man received high dosages of corticosteroids for several years because of severe asthma. There was no previous history of idiopathic CSCR. He developed three successive attacks of CSCR. On the third occasion, an unusual variant of severe CSCR was observed which presented as a bullous sensory retinal detachment with subretinal serofibrinous exudate followed by subretinal fibrosis and fibrotic scar formation with contracting bands. After tapering of the corticosteroid dosage to a low level the retinal detachment resolved without laser treatment. · Conclusion: The finding suggests that during systemic corticosteroid treatment atypical manifestations of CSCR may develop with subretinal fibrosis and scar formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 8 September 1997 Revised version received: 10 February 1998 Accepted: 18 February 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hooymans, J. Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids. Graefe's Arch Clin Exp Ophthalmol 236, 876–879 (1998). https://doi.org/10.1007/s004170050174

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004170050174

Keywords

Navigation